1.Predicted Factors of Remission in Graves' Disease.
Journal of Korean Society of Pediatric Endocrinology 2007;12(1):1-5
No abstract available.
Graves Disease*
2.Graves' Disease: Current and Future Directions.
Korean Journal of Endocrine Surgery 2001;1(1):1-5
No abstract available.
Graves Disease*
3.Guillain-Barré syndrome developing in a patient with Graves' disease.
Journal of the ASEAN Federation of Endocrine Societies 2019;34(1):103-106
Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of atypical GBS with cranial nerve involvement in a patient with GD has never been previously reported. Herein, we report a patient with GD and a rare form of pharyngo-cervico-brachial variety of GBS.
Graves Disease
4.Primary hypothyroidism following Graves' disease.
Min Ho SHONG ; Ka Hee YI ; Bo Youn CHO ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN
Journal of Korean Society of Endocrinology 1991;6(1):68-74
No abstract available.
Graves Disease*
;
Hypothyroidism*
5.Genetics of Graves' Disease.
Journal of Korean Society of Endocrinology 2003;18(1):5-11
No abstract available.
Genetics*
;
Graves Disease*
6.Applying of radioactive immune quantitative method in evaluation result of treatment I-131 in patients with Basedow’s disease
Journal of Practical Medicine 2005;503(2):59-60
175 Basedow’s disease patients (45 males and 170 females; mean age: 44.48 ± 8.89) were treated by I-131 at Bach Mai hospital and Military Hospital 103. Total T3 level in serum was 6.45 ± 2.81 nmol/l (n=146) and total T4 level was 243.58 ± 72.34 nmol/l (n=143). Before treatment T3 and T4 level increased abnormaly comparing with healthy people. By 4 months of treatment, T3 level was 2.15 ± 0.78 nmol/l and T4 level was 120.35 ± 36.81nmol/l, FT4 level was 15.67 ± 6.51pmol/l. With average dose of 6.52 ± 1.64 mCi I-131, most of patients had normalized total T3, T4 level
Graves Disease
;
Therapeutics
7.The variation of blood biochemical indices before and after treating Basedow’s disease using propyl thiouracyl
Journal of Practical Medicine 2004;480(5):19-21
After a 4 weeks of treatment by propyl thyouracil, the biochemical indices of Basedow disease had changed obviously: triiodothyronin (T3) high level (7.95 ± 1.58 nmol/l before treatment) had increased dramatically (1.98 ± 0.54 nmol/l), total thyroxin (T4) high level (257.56 ± 47.45 nmol/l before treatment) had decreased dramatically (1278.04 ± 10.82 nmol/l). FT4 serum level high level had decreased after treatment. TSF low level before treatment had increased. But after treatment glucose level had increased unsignificantly versus that before. In severe condition blood cholesterol had increased, but in moderate and mild condition, there was no change.
Blood
;
Therapeutics
;
Graves Disease
8.Use of radioiodine (I-131) in the treatment of hyperthyroidism whether causes cancer and genetic mutation or not
Journal of Medical and Pharmaceutical Information 2000;8():10-14
For the past 60 years, there have been millions with hyperthyroidism and Basedow patients treated successfully by radioiodine (I-131). The number of patients with hyperthyroidism and Basedow treated by I-131 was the same as this received operations. The radioiodine therapy was a safe, effective and economic method with easy to implement that should be selected among methods of treatment of hyperthyroidism and Basedow
Hyperthyroidism
;
Graves Disease
;
Therapeutics
9.The review of 87 patients with basedow treated by I -131 in Viet Tiep hospital.
Journal of Vietnamese Medicine 1999;232(1):87-88
During 3 years of 1994-1996, 87 patients with basedow were treated and monitored regularly in 3rd, 6th, 12nd and 24th month radioiodine I 131 in the nuclear medicine department of Viet Tiep hospital. The data of age, gender, rounds of the treatment were analysed, evaluated and compared with these in Hue Central hospital, Bach Mai hospital and Friendship hospital. The results have shown that 87.7% patients were disease free after 1 round of the treatment.
Graves Disease
;
therapy
10.Assessing the change of ultrasonic image and the thyroid volume in Basedow patients
Journal of Medical and Pharmaceutical Information 2001;(11):30-33
The thyroid volume and ultrasonic image of 356 healthy adults and 133 Basedow patients were assessed. The results are as follow: Thyroid gland of Basedow patients has low, diffusive echo and no steady border... These volumes are bigger than that of healthy adults (39.18ml+/-19.02ml, n=133 vs 12.06+/-4.07, n=356), p<0.0001.
Ultrasonics
;
Graves Disease